Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Zeptometrix NATtrol™ SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock
Designed to evaluate the performance of nucleic acid tests for determination of the presence of SARSCoV-2 Variant B.1.1.7 RNA.
Supplier: Zeptometrix NATSARS(COV2UK)ST
Description
NATtrol™ SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock is formulated with purified, intact viral particles. that have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol™ SARS-CoV-2 Variant B.1.1.7 stock in a proprietary matrix with a target concentration.
INTENDED USE:
- NATtrol™ SARS-CoV-2 Variant B.1.1.7 stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARSCoV-2 Variant B.1.1.7 RNA.
- NATtrol™ SARS-CoV2 Variant B.1.1.7 stock enables laboratories to monitor test variation, lot-to-lot test kit performance, operator variation, and can provide assistance in identifying random or systemic error.
Specifications
| ISO 13485 | |
| 1,000,000 copies/mL2 | |
| Evaluate performance of molecular tests, verification of assays, training of laboratory personnel and to monitor assay-kit lot performance |
| 2°C to 8°C | |
| Stock | |
| 1 mL |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
RUO only.
Spot an opportunity for improvement?
Provide Content Correction